OTC/SmallCap IRW

BioVaxys Enters Major Bioproduction Agreement With Wuxi Biologics (Hong Kong) Ltd. To Synthesize Proteins For Its SARS-CoV-2 Vaccine And COVID-T™ Immunodiagnostic Programs

VANCOUVER, British Columbia, March 15, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer applications, announced today that it has entered into a major bioproduction agreement w...

2021-03-15 20:00 1554

Sasol issues US dollar senior notes

JOHANNESBURG, March 12, 2021 /PRNewswire/ -- Sasol Limited ("Sasol") herewith announces that its wholly owned subsidiary Sasol FinancingUSA LLC (the "Issuer") has priced an offering of US$-denominated, SEC-registered notes (the "Notes"), including$650 million of senior notes due 2026 (the "2026 N...

2021-03-12 13:29 5237

China grants Lleida.net its fifth patent

MADRID, March 4, 2021 /PRNewswire/ -- The intellectual property authority of the People's Republic of China have granted Lleida.net its fifth patent in that Asian country. The patent, which is valid for a period of 20 years, corresponds to Lleida.net's method for certifying an electronic mail co...

2021-03-04 20:12 2018

Quarterback Services, Archer's local agent in Malaysia, secures 1-year extension of PETRONAS Carigali contract for Well Integrity Services

STOCKHOLM, March 3, 2021 /PRNewswire/ -- Quarterback Services Sdn Bhd, the local agent of Archer Well Company (M) Sdn Bhd (Archer) has secured a one-year extension with PETRONAS Carigali Sdn Bhd (PETRONAS Carigali), a subsidiary of PETRONAS, for the provision of well downhole leak detection servi...

2021-03-03 17:38 948

Cipla Gulf Expands Partnership with Alvotech for Commercialization of Biosimilars in Australia and New Zealand

MUMBAI, India, March 2, 2021 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its subsidiary, Cipla Gulf FZ LCC ("Cipla Gulf') is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines inAustra...

2021-03-02 22:05 5003

Kazia Licenses Cantrixil, a Clinical-stage, First-in-class Ovarian Cancer Drug Candidate, to Oasmia Pharmacetical AB

SYDNEY, March 2, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into an exclusive worldwide license agreement with Oasmia Pharmaceutical AB (STO: OASM), an innovation-focuse...

2021-03-02 07:00 3159

BioVaxys Expanding Technology Platform To Address Emerging SARS-CoV-2 Variants

BVX-0320 and Covid-T to have capability to address UK, Brazilian and South African Virus Variants VANCOUVER, B.C., March 1, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF)("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer app...

2021-03-01 21:00 3388

Announcement of change in the total number of votes in AB SKF

GOTHENBURG, Sweden, Feb. 26, 2021 /PRNewswire/ -- Due to a conversion of shares from Series A to Series B in accordance with AB SKF's Articles of Association, the Company confirms the following. As per 26 February, the Company's share capital amounts to SEK 1,138,377,670 and the total number of ...

2021-02-26 17:27 5709

Electrolux publishes 2020 Annual Report

STOCKHOLM, Feb. 25, 2021 /PRNewswire/ -- Electrolux Annual Report for 2020 has been published on the Group's website as of today. The Annual Report can be downloaded in pdf format here and will be distributed inmid-March 2021 to shareholders who have requested it. "The coronavirus pandemic in 20...

2021-02-25 15:53 4008

Elekta appoints Johan Adebäck as Chief Financial Officer

STOCKHOLM, Feb. 25, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that Johan Adebäck has been appointed as permanent Chief Financial Officer with immediate effect. He has held the position of Acting CFO sinceJune 2, 2020. Prior to the Acting CFO position, Johan Adebäck had been Group Tr...

2021-02-25 14:52 4099

Notice of Ericsson's Annual General Meeting 2021

STOCKHOLM, Feb. 23, 2021 /PRNewswire/ -- The Annual General Meeting of shareholders of Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) will be held on Tuesday, March 30, 2021. Due to the COVID-19 pandemic, the Board of Directors has decided that the Annual General Meeting of shareholders 2021 will...

2021-02-23 16:01 2441

BioVaxys Announces Appointment To Its Scientific Advisory Board

VANCOUVER, B.C., Feb. 22, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), a biotechnology company that is advancing viral and oncology vaccine platforms as well as immuno-diagnostic products, today announced the appointment of Kartik Chandran Ph.D....

2021-02-22 21:00 916

China Telecom Honored with Three Awards including "Platinum Award", "Best CEO" and "Best Investor Relations Team" by The Asset

HONG KONG, Feb. 22, 2021 /PRNewswire/ -- China Telecom Corporation Limited ("China Telecom" or "the Company"; HKEx: 00728; NYSE: CHA) is pleased to announce that the Company was accredited with "Platinum Award – Excellence in Environmental, Social and Governance" in the poll of "ESG Corporate Awa...

2021-02-22 16:30 3196

Sasol delivered a good set of results for the six months ended 31 December 2020

JOHANNESBURG, Feb. 22, 2021 /PRNewswire/ -- Sasol delivered a good set of results for the six months ended31 December 2020. Our earnings increased by more than 100% to R15,3 billion from R4,5 billion in the prior period. Despite a 23% decrease in the rand/barrel oil price, our adjusted EBITDA de...

2021-02-22 15:21 2023

Elekta establishes office in Egypt to meet growing need for precision radiation medicine

STOCKHOLM, Feb. 22, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it will establish a permanent office inCairo, Egypt, to address the shortage of radiotherapy delivery systems and software solutions that play an integral part in treating cancer and brain disorders. To strengthen i...

2021-02-22 15:03 5675

BioVaxys and BioElpida Sign Term Sheet for Clinical Grade BVX-0918A Bio-production

SIGNIFICANT ADVANCEMENT TOWARDS LAUNCH OF PHASE I OVARIAN CANCER VACCINE TRIAL VANCOUVER, BC, Feb. 18, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") announced today that it has signed a Term Sheet ("Term Sheet") with BioElpida S.A.S. ...

2021-02-18 21:00 3939

Crunchfish enrolled to leading international payment network's partner program

STOCKHOLM, Feb. 18, 2021 /PRNewswire/ -- Crunchfish AB ("Crunchfish") announces its enrolment into a leading international payment network's partner program with its Digital Cash solutions. As a technology partner, Crunchfish will get access to specifications and toolkits enabling integration wit...

2021-02-18 16:12 6748

Nel ASA: Fourth quarter 2020 financial results

OSLO, Norway, Feb. 18, 2021 /PRNewswire/ -- Nel ASA (Nel) reported revenues of NOK 229.1 million in the fourth quarter of 2020, up from NOK 175.9 million in the same quarter of 2019 and an EBITDA of negativeNOK 96.2 million (Q4 2019: -41.7) incl. one-offs, ramp-up cost and aNOK 20 million provisi...

2021-02-18 14:59 4139

RedHill Biopharma Announces First Patient Dosed in U.S. Phase 2/3 COVID-19 Outpatient Study with RHB-107

- The U.S. Phase 2/3 study with once-daily, orally-administered RHB-107 (upamostat) evaluates treatment of patients with symptomatic COVID-19 who do not require hospitalization - the vast majority of patients - RHB-107 is a novel serine protease inhibitor targeting human cell factors involved in...

2021-02-17 20:00 2340

Notice convening the Annual General Meeting of AB Electrolux

STOCKHOLM, Feb. 15, 2021 /PRNewswire/ -- The shareholders of AB Electrolux, reg. no. 556009-4178, are hereby given notice of the Annual General Meeting to be held onThursday, March 25, 2021. Due to the coronavirus, the Board of Directors has decided that the Annual General Meeting should be cond...

2021-02-15 20:42 3867
1234567 ... 37